Expert Perspectives on the Treatment of DVT/PE and Reduction in the Risk of Recurrent DVT/PE, With a Focus on DVT/PE Patients With Obesity and/or Cancer

Program Description: Distinguished faculty will provide expert perspectives on the treatment of DVT/PE and reduction in the risk of recurrent DVT/PE in patients at continued risk for recurrent DVT and/or PE. In addition, they will discuss the treatment of and reduction in the risk of recurrent DVT/PE in patients with obesity and/or cancer.

Faculty: Parth Rali, MD, Jerrica Waggoner, PharmD, BCPS, BCCP, James Williams, MS, DO, FACEP

Outcomes of Patient Self-Testing for Warfarin Therapy: Key Findings from Retrospective Studies

Program Description: Session will highlight findings from two retrospective studies on patient self-testing for warfarin therapy. The first study looked at virtual versus in-person education for PST for warfarin therapy, showing that virtual education is effective and should continue to be an option. The second study was a retrospective claims-based analysis looking at clinical outcomes of home INR testing (patient self-testing or PST). The study showed lower rates of adverse events including deep venous thrombosis, pulmonary embolism, bleeding, and stroke as well as fewer emergency department visits among self-testing patients versus those who had office/lab-based monitoring.

Registration: Please register to attend the session here. Note: Registration is not required to attend, but is highly recommended. Priority to attend will be given to those that pre-register for the session.

Anticoagulation Reversal: Real-World Data Matters, Too

Program Description: Introduction and assessment of real-world data (RWD) is critically important for FXa inhibitor-related bleeds in treatment-emergent situations, particularly since this crucial information has been limited to date within a complex clinical landscape. Join experts to explore how reversal agents can manage life-threatening bleeds in the presence of anticoagulation and learn how the latest published RWD guide reversal and repletion strategies in anticoagulated patients.

Continuing Education Information: In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Registration: Please register to attend the session here. Note: Registration is not required to attend, but is highly recommended. Priority to attend will be given to those that pre-register for the session.